Laura Gault's most recent trade in Sage Therapeutics Inc was a trade of 685 Common Stock done at an average price of $7.2 . Disclosure was reported to the exchange on Feb. 13, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Sage Therapeutics Inc | Laura Gault | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.18 per share. | 13 Feb 2025 | 685 | 34,649 (0%) | 0% | 7.2 | 4,918 | Common Stock |
| Sage Therapeutics Inc | Laura Gault | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2025 | 24,000 | 35,334 (0%) | 0% | 0 | Common Stock | |
| Sage Therapeutics Inc | Laura Gault | Chief Medical Officer | 05 Aug 2024 | 13,500 | 14,025 (0%) | 0% | 0 | Common Stock | ||
| Sage Therapeutics Inc | Laura Gault | Chief Medical Officer | 05 Aug 2024 | 3,288 | 10,737 (0%) | 0% | 9.0 | 29,460 | Common Stock | |
| Sage Therapeutics Inc | Laura Gault | Chief Medical Officer | 13 Feb 2024 | 22,500 | 22,500 | - | - | Stock Option (Right to Buy) | ||
| Sage Therapeutics Inc | Laura Gault | Chief Medical Officer | 13 Feb 2024 | 11,250 | 11,477 (0%) | 0% | 0 | Common Stock | ||
| Sage Therapeutics Inc | Laura Gault | Chief Medical Officer | 13 Feb 2023 | 2,660 | 2,660 | - | - | Stock Option (Right to Buy) | ||
| Sage Therapeutics Inc | Laura Gault | Chief Medical Officer | 01 Nov 2022 | 64,410 | 64,410 | - | - | Stock Option (Right to Buy) |